Benedikt Hochkirchen
Vorstandsvorsitzender bei AMBOSS GmbH
Ursprung des Netzwerks ersten Grades von Benedikt Hochkirchen
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Arcadia Beteiligungen Bensel Tiefenbacher & Co. GmbH
Arcadia Beteiligungen Bensel Tiefenbacher & Co. GmbH Investment ManagersFinance Arcadia Beteiligungen Bensel Tiefenbacher & Co. GmbH (Arcadia) is an independent German private equity firm which was founded in 2000 by Wolfgang Bensel, Christoph Tiefenbacher and Mathias Turwitt. Headquartered in Hamburg, Arcadia manages the Arcadia private equity funds, backed by large family assets, pension funds and insurance companies.
7
| Private Company | Investment Managers | 7 |
AMBOSS GmbH
AMBOSS GmbH Miscellaneous Commercial ServicesCommercial Services AMBOSS GmbH owns and operates a web based platform for training physicians. It specializes in medicine, medical knowledge, health, medical students, e-learning, and clinical decision support. The company was founded by Kenan Hasan, Madjid Salimi and Sievert Weiss in November 2011 and is headquartered in Berlin, Germany.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Benedikt Hochkirchen
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Investment Managers | Private Equity Investor | |
Quanta Dialysis Technologies Ltd.
Quanta Dialysis Technologies Ltd. Medical SpecialtiesHealth Technology Quanta Dialysis Technologies Ltd. develops haemodialysis systems. The firm's SC+ is a performance, portable, compact haemodialysis system providing clinical efficacy utilising flow rates typically used on traditional machines. It offers SelfCare+, a haemodialysis machine for dialysis patients to control their disease and determine the treatment regime and care. The company was founded by Clive Henrey Buckberry, John Eric Milad and Martin Johnson in 2008 and is headquartered in Alcester, the United Kingdom. | Medical Specialties | Director/Board Member | |
H.I.G. European Capital Partners GmbH | Investment Managers | Corporate Officer/Principal | |
Blackrock Microsystems, Inc.
Blackrock Microsystems, Inc. Packaged SoftwareTechnology Services Blackrock Microsystems, Inc. is a platform company that specializes in brain-computer interface (BCI) technology and the development of implantable solutions that improve human lives. The company is based in Salt Lake City, UT and has subsidiaries in the United States. Blackrock's precision electrode technology is at the core of many worldwide innovations in BCI, enabling dozens of early users to regain their ability to see, hear, move, and talk. Blackrock Microsystem's mission is to provide innovative tools and neurotech expertise to translate technology into novel, implantable clinical solutions that improve human lives. The company was founded in 2008 by Marcus Gerhardt and Florian Solzbacher, with Marcus Gerhardt serving as the CEO since then. | Packaged Software | Director/Board Member | |
Deposit Solutions GmbH
Deposit Solutions GmbH Packaged SoftwareTechnology Services Deposit Solutions GmbH provides software and service for financial industry. It offers services to real estate and finance markets. The firm offers the proprietary technology directly to banks to integrate into their own retail offering as the first open architecture platform for retail savings deposits in Europe. The company was founded by Tim Sievers in April 2011 and is headquartered in Hamburg, Germany. | Packaged Software | Chief Executive Officer | |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Biotechnology | Director/Board Member | |
Definiens AG
Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Packaged Software | Director/Board Member | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
Oxford Immunotec Ltd.
Oxford Immunotec Ltd. Medical SpecialtiesHealth Technology Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom. | Medical Specialties | Director/Board Member | |
Sovicell GmbH
Sovicell GmbH Pharmaceuticals: MajorHealth Technology Sovicell GmbH provides drug discovery services. It offers ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicology) to obtain pharmacokinetic data about their drug candidates or other test substances. The firm's products include plasma protein binding, brain tissue binding, brain-to-plasma distribution, microsomal binding and intestinal absorption. The company was founded in 1994 and is headquartered in Leipzig, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Director/Board Member | |
OXFORD IMMUNOTEC GLOBAL PLC | Medical Specialties | Director/Board Member | |
IMPLANET SA | Medical Specialties | Director/Board Member | |
Ambu Innovation GmbH
Ambu Innovation GmbH Medical SpecialtiesHealth Technology Ambu Innovation GmbH engages in the development and distribution of single-use and light-weight robotically-assisted high definition endoscopy products in the field of gastroenterology and gastro-intestinal surgery. Its products include invendoscope SC210, invendo ScopeController, and invendo SPU E210. The company was founded in 1992 and is headquartered in Kissing, Germany. | Medical Specialties | Director/Board Member | |
Active Equity Management GmbH | Investment Managers | Director/Board Member |
Statistik
International
Deutschland | 12 |
Vereinigtes Königreich | 4 |
Frankreich | 3 |
Vereinigte Staaten | 2 |
Sektoral
Health Technology | 11 |
Finance | 4 |
Technology Services | 4 |
Consumer Services | 2 |
Operativ
Director/Board Member | 14 |
Private Equity Investor | 8 |
Chief Executive Officer | 3 |
Corporate Officer/Principal | 2 |
Founder | 2 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Benedikt Hochkirchen
- Unternehmensverbindungen